Home > Insider Trading > Filing (0001213900-21-006834)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1553643	Relmada Therapeutics Inc.	RLMD	Pharmaceutical Preparations (2834)	455401931

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1565832	Sergio Traversa	C/O Relmada Therapeutics, Inc. 880 Third Avenue, 12Th Floor New York NY 10022	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-02-02	3,278	$3.24	92,052	No	4	M	Direct
Common Stock	Disposition	2021-02-02	3,178	$35.08	88,874	No	4	S	Direct
Common Stock	Disposition	2021-02-03	100	$35.00	88,874	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2021-02-02	3,278	$0.00	3,278	$3.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
145,144	2017-10-20	2027-10-20	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effectuated pursuant to a Rule 10b51 trading plan adopted by the reporting person on December 22, 2020.
The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
Sales prices range from $35.00 to $35.30 per share, inclusive.
The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.
Not applicable.